Edge Wealth Management LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Edge Wealth Management LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2021$4,000
-20.0%
3270.0%0.00%0.0%
Q3 2021$5,000
-16.7%
3270.0%0.00%0.0%
Q2 2021$6,0000.0%3270.0%0.00%0.0%
Q1 2021$6,0000.0%3270.0%0.00%0.0%
Q4 2020$6,0000.0%3270.0%0.00%0.0%
Q3 2020$6,000
-75.0%
327
-75.5%
0.00%
-80.0%
Q2 2020$24,000
+20.0%
1,3330.0%0.01%
+25.0%
Q1 2020$20,000
-23.1%
1,3330.0%0.00%
-20.0%
Q4 2019$26,000
-35.0%
1,333
-43.6%
0.01%
-44.4%
Q3 2019$40,000
-4.8%
2,3640.0%0.01%0.0%
Q2 2019$42,000
-23.6%
2,364
-13.0%
0.01%
-35.7%
Q1 2019$55,0002,7160.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2020
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders